⌕
Regeneron Pharmaceuticals · REGN · Nasdaq
Tenet 64 · Solid
Compare
$952.40−0.32%At closeTenet 64 · Solid
$952.40−3.07 (−0.32%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
$951.01−1.39 (−0.15%)
After hours: Nov 16, 2026, 4:43 PM ET

Regeneron Pharmaceuticals (REGN) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

62
VALUE
Fairly priced
in line with its peers
66
QUALITY
Decent
mid-pack profitability
70
HEALTH
Sturdy
conservative balance sheet
58
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at a fair price: value 62, quality 66, health 70, growth 58, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
62nd pctilein line with its peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.5.3%69th pctile
P/E20.972nd pctile
P/B3.069th pctile
P/FCF25.845th pctile
EV / EBITDA17.053rd pctile
70th pctileconservative balance sheet
Current ratio3.3554th pctile
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.2.7257th pctile
Net debt / EBITDADebt less cash and all investments, including long-term stakes, over EBITDA, as the data vendor builds it−1.4×77th pctile
Interest coverage104.2×97th pctile
Debt / equity0.0668th pctile
66th pctilemid-pack profitability
ROIC12%78th pctile
ROE15%72nd pctile
Gross margin85.8%79th pctile
Net margin28.5%92nd pctile
Income quality (CFO/NI)1.01×14th pctile
Piotroski F5 / 949th pctileown record too short
Altman Z7.876th pctile
58th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin22.6%85th pctile
the receipts behind the numbers above
Greenblatt earnings yield5.3%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC12%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage104.2× EBIT ÷ interest expense, ranked within sector peers.
Percentiles computed nightly against 313 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 13, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.